[1]
N. Ibadullaeva, A. Khikmatullaeva, U. Mirzaev, N. Kan, M. Bobkova, and E. Musabaev, “Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients”, J Infect Dev Ctries, vol. 18, no. 05, pp. 672–678, May 2024.